24th January 2024

New LINC Grants aim to tackle unmet medical need

Support for cancer, children’s immunity and blood infection research

Latest News

10 May 2021

FDA approval for new saliva oral and throat cancer diagnostic

Research by TRI-affiliated A/Prof Chamindie Punyadeera has led to the commercialisation of a new diagnostic.
More about FDA approval for new saliva oral and throat cancer diagnostic
16 April 2021

Potential New Treatment Could Help Save COVID-19 Patients

Anti-inflammatory drug, IC14, enters Phase II clinical trial to treat severely ill COVID-19 patients.
More about Potential New Treatment Could Help Save COVID-19 Patients
25 March 2021

US Department of Defense breast cancer grant

Dr Fernando Guimaraes has been awarded US$750K to progress a new breast cancer treatment
More about US Department of Defense breast cancer grant
24 March 2021

Breakthrough therapy cures lymphoma patient

A Mater Research team has cured a patient of a rare type of lymphoma
More about Breakthrough therapy cures lymphoma patient
24 March 2021

Anticancer and Antimicrobial peptide treatments

QUT's Dr Sónia Henriques, is developing selective and potent anticancer peptide-based treatments.
More about Anticancer and Antimicrobial peptide treatments
22 March 2021

New funding for COVID-19 research

Mater Research's TRI-based Dr Mitchell Sullivan has received funding for a COVID-19 research project.
More about New funding for COVID-19 research

Pages

Events

26 February 2024 12:00 PM1:00 PM

Medical Grand Rounds

Medical Grand Rounds are held every Monday and can be viewed via video conference.
More about Medical Grand Rounds
26 February 2024 12:00 PM1:00 PM

Mater Research Seminar Series

Presentations from a Mater Group Leader and Honours' Students.
More about Mater Research Seminar Series
27 February 2024 10:00 AM12:00 PM

Preparing yourself for clinical translation & the importance of picking the right target

The Queensland Government's Department of State Development and Infrastructure has partnered with Brandon BioCatalyst to deliver a skills gap program for Queensland-based biomed founders and businesses. This first seminar will focus on therapeutic development planning, early commercialisation considerations and spin-out creation.
More about Preparing yourself for clinical translation & the importance of picking the right target